Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Ares Villagrasa
  • Virginia Hernandez-Gea
  • Ramon Bataller
  • Alvaro Giraldez
  • Bogdan Procopet
  • Lucio Amitrano
  • Candid Villanueva
  • Dominique Thabut
  • Luis Ibanez-Samaniego
  • Agustin Albillos
  • Christophe Bureau
  • Jonel Trebicka
  • Elba Llop
  • Wim Laleman
  • J. M. Palazon
  • Jose Castellote
  • Susana L. Rodrigues
  • Lise N. Gluud
  • Carlos Ferreira
  • Nuria Canete
  • Manuel Rodriguez
  • Arnulf L. Ferlitsch
  • Jose Mundi
  • Henning Gronbaek
  • Manuel Hernandez-Guerra
  • Romano Sassatelli
  • Alessandra Dell'Era
  • Marco G. Senzolo
  • Juan Abraldes
  • Alexander Zipprich
  • Meritxell Casas
  • Helena Masnou
  • Massimo Primignani
  • Aleksander Krag
  • Gilberto Silva-Junior
  • Manuel Romero-Gomez
  • Marcel A. Tantau
  • Maria Guardascione
  • Edilmar Alvarado
  • Marika Rudler
  • Rafael Banares
  • Javier A. Martinez
  • Marie Robic
  • Christian L. Jansen
  • Jose Calleja
  • Frederik Nevens
  • Gluud, Lise Lotte
  • Jaime Bosch
  • Meritxell C. Ventura-Cots
  • Juan Garcia-Pagan
  • Joan Genesca
  • Int Variceal Bleeding
  • Baveno Cooperation

Background & AimsAlcohol-related hepatitis (AH) encompasses a high mortality. AH might be a concomitant event in patients with acute variceal bleeding (AVB). The current study aimed to assess the prevalence of AH in patients with AVB and to compare the clinical outcomes of AH patients to other alcohol-related liver disease (ALD) phenotypes and viral cirrhosis. MethodsMulticentre, observational study including 916 patients with AVB falling under the next categories: AH (n = 99), ALD cirrhosis actively drinking (d-ALD) (n = 285), ALD cirrhosis abstinent from alcohol (a-ALD) (n = 227) and viral cirrhosis (n = 305). We used a Cox proportional hazards model to calculate adjusted hazard ratio (HR) of death adjusted by MELD. ResultsThe prevalence of AH was 16% considering only ALD patients. AH patients exhibited more complications. Forty-two days transplant-free survival was worse among AH, but statistical differences were only observed between AH and d-ALD groups (84 vs. 93%; p = 0.005), when adjusted by MELD no differences were observed between AH and the other groups. At one-year, survival of AH patients (72.7%) was similar to the other groups; when adjusted by MELD mortality HR was better in AH compared to a-ALD (0.48; 0.29-0.8, p = 0.004). Finally, active drinkers who remained abstinent presented better survival, independently of having AH. ConclusionsContrary to expected, AH patients with AVB present no worse one-year survival than other patients with different alcohol-related phenotypes or viral cirrhosis. Abstinence influences long-term survival and could explain these counterintuitive results.

OriginalsprogEngelsk
TidsskriftLiver International
Vol/bind43
Udgave nummer7
Sider (fra-til)1548-1557
Antal sider10
ISSN1478-3223
DOI
StatusUdgivet - 2023

ID: 351050417